Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimiter S Dimitrov

Showing results (161-170 of 284) with videos related to

Pageof 29
Sort By:
Mabs|December 18, 2014
Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugarZhongyu Zhu, Boopathy Ramakrishnan, Jinyu Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2019
Cartilage-Targeted IGF-1 Treatment to Promote Longitudinal Bone GrowthJulian C Lui, Max Colbert, Crystal Sao Fong Cheung, et al.
The Journal of Biological Chemistry|July 17, 2021
Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22June Ereño-Orbea, Xianglei Liu, Taylor Sicard, et al.
Scientific Reports|August 24, 2017
One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected CellsWei Li, Yanling Wu, Desheng Kong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
Molecular structures of trimeric HIV-1 Env in complex with small antibody derivativesJoel R Meyerson, Erin E H Tran, Oleg Kuybeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environmentTaichi Kimura, Takeshi Kuwata, Satoshi Ashimine, et al.
Frontiers in Immunology|February 10, 2023
Human antibodies targeting ENPP1 as candidate therapeutics for cancersXiaojie Chu, Du-San Baek, Wei Li, et al.
Vaccine|October 4, 2020
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in miceXianglei Liu, Aleksandra Drelich, Wei Li, et al.
Nature Communications|September 16, 2015
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibodyTianlei Ying, Ponraj Prabakaran, Lanying Du, et al.
Molecular Immunology|March 10, 2022
Functional reconstitution of the MERS CoV receptor binding motifLakshminarasaiah Uppalapati, Anna Roitburd-Berman, Yael Weiss-Ottolenghi, et al.
Pageof 29

Showing results (161-170 of 284) with videos related to

Sort By:
Pageof 29
Mabs|December 18, 2014
Site-specific antibody-drug conjugation through an engineered glycotransferase and a chemically reactive sugarZhongyu Zhu, Boopathy Ramakrishnan, Jinyu Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2019
Cartilage-Targeted IGF-1 Treatment to Promote Longitudinal Bone GrowthJulian C Lui, Max Colbert, Crystal Sao Fong Cheung, et al.
The Journal of Biological Chemistry|July 17, 2021
Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22June Ereño-Orbea, Xianglei Liu, Taylor Sicard, et al.
Scientific Reports|August 24, 2017
One-domain CD4 Fused to Human Anti-CD16 Antibody Domain Mediates Effective Killing of HIV-1-Infected CellsWei Li, Yanling Wu, Desheng Kong, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 26, 2012
Molecular structures of trimeric HIV-1 Env in complex with small antibody derivativesJoel R Meyerson, Erin E H Tran, Oleg Kuybeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 24, 2009
Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environmentTaichi Kimura, Takeshi Kuwata, Satoshi Ashimine, et al.
Frontiers in Immunology|February 10, 2023
Human antibodies targeting ENPP1 as candidate therapeutics for cancersXiaojie Chu, Du-San Baek, Wei Li, et al.
Vaccine|October 4, 2020
Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in miceXianglei Liu, Aleksandra Drelich, Wei Li, et al.
Nature Communications|September 16, 2015
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibodyTianlei Ying, Ponraj Prabakaran, Lanying Du, et al.
Molecular Immunology|March 10, 2022
Functional reconstitution of the MERS CoV receptor binding motifLakshminarasaiah Uppalapati, Anna Roitburd-Berman, Yael Weiss-Ottolenghi, et al.
Pageof 29